PANCOSMA and BASF settle their patent dispute with BIOCHEM on the metal-glycine complex patents

Ludwigshafen and Lohne, Germany, and Le Grand-Saconnex, Switzerland, July 22, 2019 – PANCOSMA SA and BASF SE settled their patent dispute with BIOCHEM Zusatzstoffe Handels- und Produktionsgesellschaft mbH concerning the intellectual property rights of metal-glycinates. The patent dispute was settled in Germany on June 24, 2019.

As a result of the settlement, the glycinate IP rights EP 1453843 B1 and EP 2161075 B1 are maintained and BIOCHEM was granted a license thereto.

The companies are pleased with the outcome and are looking forward to further develop metal glycinates to the benefit of their respective customers.

Glycinates are organically bound trace elements used for animal nutrition. Such trace elements are essential micronutrients that enhance the vitality and productivity of animals. The patent-protected glycinates comprise copper, iron, manganese, and zinc. These glycinates are patent protected due to a unique technology that provides free-flowing granules and enables outstanding bioavailability. In addition, they show excellent mixing properties and easily dissolve in water. Due to their superior bioavailability, glycinates optimally supply the animal with trace elements, and the environment benefits from less excreted trace elements.

Pancosma is part of the ADM Animal Nutrition division, headquartered in Rolle, Switzerland. The Pancosma brand is a global leader in developing, manufacturing and distributing a wide range of innovative feed additives, and is present in more than 75 countries. The Pancosma portfolio consists of phytonutrient-based technologies, organic trace minerals, and palatants, and continually strives to deliver innovative solutions for animal nutrition through its commitment to research & development.